iShares Biotechnology ETF (IBB)
$137.04
0.82 (0.59%)
IBB Stock Quote Delayed 30 Minutes
Biogen Inc (BIIB): Profit From the BIIB Stock Bears
Love it or hate it, the severe chop in Big Pharma presents opportunities to create income. Sell risk against value levels in Biogen (BIIB) stock.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
649,273
Day's Range
$136.60 - $138.80
52-Week Range
$123.96 - $150.57
Dividend & Yield
$0.40 (0.29%)
IBB Stock Predictions, Articles, and iShares Biotechnology ETF News
iShares Nasdaq Biotechnology Index (ETF) (IBB) Is at a Crossroads
The iShares Nasdaq Biotechnology ETF (IBB) is showing relative strength, but the IBB ETF must overcome this hurdle to continue rallying.
Study Free Profits From iShares Nasdaq Biotechnology Index (ETF) (IBB) Stock
The meme that biotechs are untouchable for as long as Trump is tweeting about price wars is ebbing. Go long IBB with room for error.
Catch Valeant Pharmaceuticals Intl Inc (VRX) Stock for Free
Valeant Pharmaceuticals (VRX) has no shortage of haters, but don't be shy on red days. Go long VRX stock with a huge buffer zone!
Get in Biogen Inc (BIIB) Stock Before It Breaks Out
Biogen (BIIB) hasn't had much love from Wall Street this year, but its fundamentals are strong. Go long this popularity bottom in BIIB stock.
Why Valeant Pharmaceuticals Intl Inc (VRX) Stock Will Finally Stabilize
Valeant Pharmaceuticals (VRX) is finally getting its house in order. Don't expect VRX stock to explode, but it will get a lift.
iShares Nasdaq Biotechnology Index (ETF) (IBB) Shows Signs of Hope
The iShares Nasdaq Biotechnology ETF (IBB) gave off an initial signal of hope for a better rally in biotech stocks. Here's how to handle IBB.
Go Long Bristol-Myers Squibb Co (BMY) Stock for Panic Profits!
Pharmaceutical stocks like Bristol-Myers Squibb (BMY) have been toxic for months, but BMY stock is about to turn lemons into lemonade.
Buy Today’s Trump Dump in Biotech Stocks – XBI IBB
Biotech stocks and ETFs like iShares' IBB and SPDR's XBI were hammered Wednesday on Donald Trump's drug pricing comments. Opportunity knocks.
Trade Valeant Pharmaceuticals Intl Inc (VRX) Stock for Free Profits
Most traders look to hit home runs with Valeant Pharmaceuticals (VRX). I suggest simply settling for base hits on VRX stock.
Dow Jones Industrial Average Continues to Skyrocket
The Dow Jones Industrial Average may be overbought, but it seems like the markets are still pointed upward for now.
Amgen, Inc. (AMGN) Stock Might Be on Santa’s Buy List
Amgen (AMGN) just flashed a little encouragement to the bulls. While Amgen stock looks stuck, it very well could break out of its funk.
Is the IShares Nasdaq Biotechnology Index (ETF) (IBB) Verging on a Breakout?
The IBB ETF remains stuck in a well-defined trading range, but what would constitute to a buy signal and break out of the range?
Does Your ETF Portfolio Need a Trump Transformation?
While a number of stocks and ETFs are getting a 'Trump bump,' don't go blindly chasing every trend on a whim.
5 Top Biotech Stocks to Buy on Trump Victory
The case for buying biotech stocks has strengthened following the election of Donald Trump to the White House.
3 Big Stock Charts: iShares NASDAQ Biotechnology Index (ETF) (IBB), VelocityShares Daily Inverse VIX Short Term ETN (XIV) and Nvidia Corporation (NVDA)
iShares Biotechnology (IBB), VelocityShares Daily Inverse VIX ETN (XIV) and Nvidia (NVDA) are likely to benefit as the market becomes comfortable with President-elect Trump's victory.
Buy the SPDR S&P Biotech (ETF) (XBI) TODAY – Here’s Why
Biotech stocks and the SPDR S&P Biotech ETF (XBI) just shook off a major bugaboo in Hillary Clinton. The XBI ETF will soar as a result.
